Pay-As-You-Go Effects for S. 3525, as Introduced on September 12, 2012
Cost Estimates Search
- Cost Estimate
- Cost Estimate
CBO Estimate of the Statutory Pay-As-You-Go Effects for Senate Amendment 2122 in the Nature of a Substitute to S. 3187,the Food and Drug Administration Safety and Innovation Act, with Further Amendments Adopted by the Senate through May 24, 2012
- Cost Estimate
CBO Estimate of the Statutory Pay-As-You-Go Effects for Senate Amendment 2122 in the Nature of a Substitute to S. 3187, the Food and Drug Administration Safety and Innovation Act
- Cost Estimate
Estimate of direct spending and revenues effects for the bill as cleared by the Congress on November 19, 2004
- Cost Estimate
Estimate of direct spending and revenues effects for the bill as cleared by the Congress on October 7, 2004
- Cost Estimate
Cost estimate for the bill as passed by the Senate on July 15, 2004
- Cost Estimate
Cost estimate for the bill as passed by the Senate on June 23, 2004
- Cost Estimate
Direct spending and revenues effects estimate for the bill as cleared by the Congress on June 24, 2004, and signed by the President on June 30, 2004
- Cost Estimate
Cost estimate for the bill as cleared by the Congress on June 21, 2004
- Cost Estimate
Cost estimate for the bill as introduced on April 7, 2004.